Evidence map›Paper›PMID 23720012›Full record

ReviewPediatric nephrology (Berlin, Germany)2014

DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.

International Alport Mutation Consortium, Judy Savige, Elisabet Ars, Richard G H Cotton, David Crockett, Hayat Dagher, Constantinos Deltas, Jie Ding, Frances Flinter, Genevieve Pont-Kingdon and 3 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A novel missense mutation ofTranslational pediatrics · 2020
    Article
  5. Article
  6. Article
  7. Novel deletion mutation in a Chinese family with X-linked alport syndrome.International journal of clinical and experimental pathology · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 6 countries.

International Alport Mutation Consortium
Judy Savige
Elisabet Ars
Richard G H Cotton
David Crockett
Hayat Dagher
Constantinos Deltas
Jie Ding
Frances Flinter
Genevieve Pont-Kingdon
Nizar Smaoui
Roser Torra
Helen Storey
Guy's and St Thomas' NHS Foundation Trust · GBARUP Institute for Clinical and Experimental PathologyARUP Laboratories (United States) · USNorthern Health · AUNorthern Hospital · AUPeking University · CNPuigvert Foundation · ESUniversitat Autònoma de Barcelona · ESUniversity of Cyprus · CYUniversity of Melbourne · AU

Funding

Wellcome Trust 086034
6 · The paper itself

Abstract

X-linked Alport syndrome is a form of progressive renal failure caused by pathogenic variants in the COL4A5 gene. More than 700 variants have been described and a further 400 are estimated to be known to individual laboratories but are unpublished. The major genetic testing laboratories for X-linked Alport syndrome worldwide have established a Web-based database for published and unpublished COL4A5 variants ( https://grenada.lumc.nl/LOVD2/COL4A/home.php?select_db=COL4A5 ). This conforms with the recommendations of the Human Variome Project: it uses the Leiden Open Variation Database (LOVD) format, describes variants according to the human reference sequence with standardized nomenclature, indicates likely pathogenicity and associated clinical features, and credits the submitting laboratory. The database includes non-pathogenic and recurrent variants, and is linked to another COL4A5 mutation database and relevant bioinformatics sites. Access is free. Increasing the number of COL4A5 variants in the public domain helps patients, diagnostic laboratories, clinicians, and researchers. The database improves the accuracy and efficiency of genetic testing because its variants are already categorized for pathogenicity. The description of further COL4A5 variants and clinical associations will improve our ability to predict phenotype and our understanding of collagen IV biochemistry. The database for X-linked Alport syndrome represents a model for databases in other inherited renal diseases.

Indexed as

Databases, Nucleic AcidCollagen Type IVHumansNephritis, HereditaryPhenotypeCOL4A5 protein, humanCollagen Type IV

Identifiers

PMID23720012
OpenAlexW2082454196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.